Variational AI

📍 Vancouver, Canada🗓 Founded 2019👥 23 employees💰 Last funded Jan 2025
Biotechnology Research🌐 variational.ai
Website LinkedIn
Variational AI has developed Enki, the industrys first commercially available foundation model for small-molecule drug discovery. Enki is based on a novel generative AI framework invented by Variational AI that has delivered novel and selective leads to multiple biopharma partners and customers.
4
Total investors
2
Early stage
1
Mid stage
1
Late stage
2019
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Canada
1
Investor activity2021–2025 · investors recorded per year
202122023120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Variational AI?
Variational AI has 4 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Variational AI last raise funding?
The most recent investment in Variational AI recorded on gritt.io was in January 2025.
When was Variational AI founded?
Variational AI was founded in 2019.
What industry is Variational AI in?
Variational AI operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Variational AI based?
Variational AI is headquartered in Vancouver, Canada.